Skip to content

Gross Profit at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$15.96B+9.8%
Stryker logo
StrykerSYK
$3.81B+1.8%
PDE
Pro-Dex, Inc.PDEX
$6.13M+5.8%
CONMED logo
CONMEDCNMD
$183.45M+3.2%
Vericel logo
VericelVCEL
$49.27M+35.8%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$7.76M+51.1%

Other financials

Income statement

See full
Revenue$2.1B+9.3%
Operating income$373.2M+27.7%
Net income$238.1M+30.8%
EPS (diluted)$1.22+34.1%

Balance sheet

See full
Cash & equivalents$424.2M-69.4%
Total debt$7.5B+4.1%
Total equity$12.7B+2.2%
Total assets$22.7B+2.4%

Cash flow

See full
Operating cash flow$359.4M-6.1%
CapEx$36.3M-18.6%
Free cash flow$323.1M-4.5%

Valuation

See full
Market cap$17.61B-6.5%
Enterprise value$24.66B-4.6%
P/E23.1×+0.3×
P/S2.1×-0.3×

Profitability

See full
Gross margin70%-1.0pp
Operating margin14%-3.0pp
Net margin9.1%-2.8pp
FCF margin17.3%-1.6pp

Returns & leverage

See full
Return on equity6.1%-1.2pp
Debt / equity0.6×0.0×
Current ratio1.7×-0.7×

Where this comes from

Calculated from Zimmer Biomet Holdings’s reported figures.

The official record: Zimmer Biomet Holdings’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zimmer Biomet Holdings's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zimmer Biomet Holdings's gross profit?
Zimmer Biomet Holdings (ZBH) reported gross profit of $1.51B in Q1 2026.
How has Zimmer Biomet Holdings's gross profit changed year-over-year?
Zimmer Biomet Holdings's gross profit increased by 11.1% year-over-year, from $1.36B to $1.51B.
What is the long-term trend for Zimmer Biomet Holdings's gross profit?
Over 4 years (2021 to 2025), Zimmer Biomet Holdings's gross profit has grown at a 4.2% compound annual growth rate (CAGR), from $4.87B to $5.74B.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.